{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:56:27Z","timestamp":1786737387075,"version":"build-2736575974"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Anaesth"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ija.ija_536_20","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T13:01:11Z","timestamp":1598878871000},"page":"821","source":"Crossref","is-referenced-by-count":1,"title":["Severe metabolic acidosis secondary to iatrogenic hyperglycaemia in secondary cytoreduction and hyperthermic intraperitoneal chemotherapy (HiPEC)"],"prefix":"10.4103","volume":"64","author":[{"given":"Priyanka","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Sogal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishith","family":"Govil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-5049.294068-1","doi-asserted-by":"crossref","unstructured":"Helm CW. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer: World Experience. Intraperitoneal Cancer Therapy. Totova, NJ: Humana press; 2007. p. 147-62.","DOI":"10.1007\/978-1-59745-195-6_10"},{"key":"key-10.4103\/0019-5049.294068-2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4251\/wjgo.v2.i2.68","article-title":"Hyperthermic intraperitoneal chemotherapy: Rationale and technique","author":"Gonzalez","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"key-10.4103\/0019-5049.294068-3","doi-asserted-by":"crossref","unstructured":"Garg R. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Fluid and temperature remain the culprit! Indian J Anaesth 2018;62:162-5.","DOI":"10.4103\/ija.IJA_170_18"},{"key":"key-10.4103\/0019-5049.294068-4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.egja.2013.05.005","article-title":"The perioperative course and anesthetic challenge for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","author":"Kamal","year":"2013","journal-title":"Egypt J Anaesth"},{"key":"key-10.4103\/0019-5049.294068-5","first-page":"615","article-title":"Doxorubicin caused severe hyperglycemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle","author":"de","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"key-10.4103\/0019-5049.294068-6","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4103\/ija.IJA_765_19","article-title":"Society of Onco-anaesthesia and perioperative care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)","author":"Solanki","year":"2019","journal-title":"Indian J Anaesth","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5049","issn-type":"print"}],"container-title":["Indian Journal of Anaesthesia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:53:45Z","timestamp":1786733625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ija.IJA_536_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":6,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"alternative-id":["294068"],"URL":"https:\/\/doi.org\/10.4103\/ija.ija_536_20","relation":{},"ISSN":["0019-5049"],"issn-type":[{"value":"0019-5049","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}